Live from the NIH registry
Studies recruiting near Spring Hill right now
Top 25 of 116 recruiting studies, sorted by proximity — each links to its official registry page
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Florida Cancer Specialists North / Sarah Cannon Research Institute — Trinity, Florida (22.6 mi)
· Sponsor: American Society of Clinical Oncology
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Suncoast Clinical Research Pasco County /ID# 257018 — New Port Richey, Florida (19.9 mi)
· Sponsor: AbbVie
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Colitis, Ulcerative
N/A
Observational 300 participants sought
Gastro Florida — Lutz, Florida (23.1 mi)
· Sponsor: Pfizer
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
Advanced Research Institute, Inc — New Port Richey, Florida (19.9 mi)
· Sponsor: Philip Morris Products S.A.
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (20.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
Nature Coast Clinical Research — Inverness, Florida (27.4 mi)
· Sponsor: Amgen
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Florida Cancer Specialists — Trinity, Florida (22.6 mi)
· Sponsor: Pfizer
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
Suncoast Clinical Research, Inc. — New Port Richey, Florida (19.9 mi)
· Sponsor: Eli Lilly and Company
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (20.6 mi)
· Sponsor: National Cancer Institute (NCI)
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3
Interventional 274 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (20.6 mi)
· Sponsor: SWOG Cancer Research Network
Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury
Acute Kidney Injury
N/A
Observational 100 participants sought
Morton Plant North Bay Hospital — New Port Richey, Florida (19.9 mi)
· Sponsor: BayCare Health System
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
ClearVista Clinical Research, LLC (01096) — Bayonet Point, Florida (14.1 mi)
· Sponsor: Apellis Pharmaceuticals, Inc.
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — New Port Richey, Florida (19.9 mi)
· Sponsor: 89bio, Inc.
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Access research Institute — Brooksville, Florida (10.0 mi)
· Sponsor: Boehringer Ingelheim
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Cardiovascular, Metabolic Disease
Phase 1
Interventional 90 participants sought
Research Site 19 — High Point, Florida (4.6 mi)
· Sponsor: CRISPR Therapeutics AG
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Phase 3
Interventional 1,200 participants sought
Research Site — Crystal River, Florida (29.5 mi)
· Sponsor: AstraZeneca
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (20.6 mi)
· Sponsor: NRG Oncology
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Obesity, Overweight
Phase 2
Interventional 1,481 participants sought
Suncoast Clinical Research, Inc. — New Port Richey, Florida (19.9 mi)
· Sponsor: Eli Lilly and Company
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Crohn's Disease
Phase 2
Interventional 540 participants sought
Advanced Research Institute, Inc /ID# 265548 — New Port Richey, Florida (19.9 mi)
· Sponsor: AbbVie
Freedom-1 Study for Chronic Knee Pain
Osteoarthritic Knee Pain
N/A
Interventional 100 participants sought
Florida Joint Care Institute — Trinity, Florida (22.6 mi)
· Sponsor: Curonix LLC
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Nature Coast Clinical Research — Inverness, Florida (27.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Cozy Research LLC — Wesley Chapel, Florida (20.6 mi)
· Sponsor: Boehringer Ingelheim
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Access Research Institute — Brooksville, Florida (10.0 mi)
· Sponsor: CSL Behring
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
COPD
Phase 2
Interventional 171 participants sought
Access Research Institute — Brooksville, Florida (10.0 mi)
· Sponsor: Uniquity One (UNI)
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Arthritis, Psoriatic
Phase 3
Interventional 750 participants sought
Suncoast Clinical Research — New Port Richey, Florida (19.9 mi)
· Sponsor: Janssen Research & Development, LLC